As per Fortune Business Insights, the North America Orphan Drugs Market was worth US$ 67,136.0 Mn in 2017 and will continue to rise at a steady pace until 2025. This is mainly ascribable to the rising awareness among people regarding the use of novel drugs. In addition to this, North America is expected to offer attractive growth opportunities on the back of recent FDA approvals on the development of orphan drugs. Governments in North America are increasingly spending on research and development (R&D) of orphan drugs and technologies.
Browse Complete Report Details @
According to the report, the global orphan drugs market was valued at US$ 125000 Mn in 2017 and is anticipated to reach US$ 294000 Mn by 2025. The report also stated that the market would exhibit a remarkable CAGR of 11.4% during the forecast period.
North America is expected to remain dominant in the Global Orphan Drugs Market between 2018 and 2025. Fortune Business Insights found this information in a report, titled “Orphan Drugs Market: Global Market Analysis, Insights and Forecast, 2018-2025”.
Some of the Main Key Players Covered in the Report:
Sample PDF Brochure @
- Bayer AG
- Hoffmann-La Roche Ltd.
- Alexion Pharmaceuticals Inc.
- Novo Nordisk A/S
- Novartis AG
- Bristol-Myers Squibb Company
- AstraZeneca Plc.
- Daiichi Sankyo Company Limited
- GlaxoSmithKline Plc.
- Amgen Inc.
By Therapy Area
By Drug Type
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Sales
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
The emergence of New Players to Drive the Orphan Drug Market and Increase Competition
The global orphan drugs market is anticipated to pave the way for the entry of several new players in the coming years. This is mainly because of rapid drug development and discovery over the years. Several leading companies are manufacturing orphan drugs to build a nimble and agile framework.
Some of the savvy players present in the global orphan drugs market are Actelion Pharmaceuticals Ltd., Biogen, Eli Lilly and Company, Bayer AG, Amgen Inc., and Pfizer Inc. These leading players are likely to give tough competition to the small entrants. Therefore, these small scale companies may need support from governments and other authorities to sustain in the market.
TOC followed by
- North America Orphan Drugs Market Analysis, Insights and Forecast, 2014-2025
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Therapy Area
6.3. Market Analysis, Insights and Forecast – By Distribution Channels
6.3.1. Hospital Pharmacy
6.3.2. Retail Pharmacy
6.3.3. Online Sales
6.4. Market Analysis, Insights and Forecast – By Country
7.Europe Orphan Drugs Market Analysis, Insights and Forecast, 2014-2025
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Therapy Area
………. TOC Continued………
More Trending Topics from Fortune Business Insights: